Methyl 2-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiophen-2-yl)acetate, 97%, 1g

Methyl 5-Bromo-2-trifluoromethylbenzoate, 95.0%, 100mg

tert-Butyl-N-[2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-carbamate, 97.0%, 100g

1-(4-Chlorobenzyl)-1-(4-methoxyphenyl)hydrazine, 98%, 1g

2-Amino-2,3-dimethylbutyramide, 95.0%, 100g

(S)-3-Oxocyclohexanecarboxylic acid, 98%, 250mg

1-[(1,1-Dimethylethoxy)carbonyl]-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-D-histidine, 98%, 1g

N'-aminopyridine-2-carboximidamide, 97%, 25g

Éosine Y (CI 45380), 500 g

n-Hexane, min.95%, pour la synthèse, 1L, emballage en verre

4-(5-Bromopyridin-2-yl)morpholine, 97.0%, 10g

Methyl 5-oxopyrrolidine-2-carboxylate, 97.0%, 5g

4-Bromo-2-chloro-6-methylphenol, 97.0%, 25g